Loading...

Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients with Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study

SIMPLE SUMMARY: This study aimed to investigate the efficacy of alternating lenvatinib (LEN) and trans-arterial therapy (AT) in patients with intermediate-stage hepatocellular carcinoma (HCC) after propensity score matching analysis. AT and albumin-bilirubin (ALBI) grade 1 were identified as indepen...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancers (Basel)
Main Authors: Shimose, Shigeo, Iwamoto, Hideki, Tanaka, Masatoshi, Niizeki, Takashi, Shirono, Tomotake, Noda, Yu, Kamachi, Naoki, Okamura, Shusuke, Nakano, Masahito, Suga, Hideya, Yamaguchi, Taizo, Kawaguchi, Takumi, Kuromatsu, Ryoko, Noguchi, Kazunori, Koga, Hironori, Torimura, Takuji
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2021
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7796435/
https://ncbi.nlm.nih.gov/pubmed/33466496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13010160
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!